Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000418097 | SCV000517674 | benign | not specified | 2015-12-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001662382 | SCV001876003 | benign | Combined oxidative phosphorylation defect type 17 | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001662382 | SCV002469332 | benign | Combined oxidative phosphorylation defect type 17 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003316538 | SCV004017439 | benign | Prostate cancer, hereditary, 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004709981 | SCV005247922 | benign | not provided | criteria provided, single submitter | not provided |